PM
Therapeutic Areas
Sonnet BioTherapeutics Pipeline
| Drug | Indication | Phase |
|---|---|---|
| SON-1010 | Solid Tumors | Phase 1 |
| SON-1010 + Atezolizumab | Platinum-Resistant Ovarian Cancer (PROC) | Phase 1 |
| SON-1210 | Solid Tumors (Pancreatic Cancer) | Phase 1/2a |
| SON-080 | Chemotherapy-Induced Peripheral Neuropathy (CIPN) & Diabetic Peripheral Neuropathy (DPN) | Phase 2 |